Homebuilding

The latest quarterly filing from Berkshire Hathaway (NYSE: BRK)(NYSE: BRK) revealed the Warren Buffett-led conglomerate investing in UnitedHealth Group (NYSE: UNH) and several other new positions. Market strategist Jay Woods says the filing shows how Berkshire Hathaway could be changing its ways....

U.S. stocks settled higher on Friday, with the Dow Jones index gaining around 300 points during the session following the release of inflation data. Major indices, however, recorded losses last week, with the Nasdaq Composite falling 0.7% and S&P 500 losing 0.3%. The Dow also fell 0.2% during...

Lennar Corporation (NYSE: LEN) reported third-quarter fiscal 2024 results, wherein its earnings and revenues surpassed the Zacks Consensus Estimate. On a year-over-year basis, revenues increased, given the company's emphasis on maintaining a steady production rate to drive sales momentum....

Homebuilder Lennar Corp's (NYSE: LEN) Board of Directors has increased its annual dividend to $2.00 from $1.50 per share. The move will result in a quarterly cash dividend of $0.50 per share for both Class A and Class B common stock. The dividend is payable on February 7, 2024,...

Raymond James analyst Buck Horne reiterated an Outperform rating on the shares of Lennar Corp (NYSE: LEN) raised the price target from $150 to $165. Lennar reported core EPS of $5.17 for its F4Q23 results, topping estimates of $4.59.  Another upside quarterly result...

Gainers TransCode Therapeutics, Inc. (NASDAQ: RNAZ) shares jumped 308% to $2.71 after the company announced pre-clinical gliblastoma results with its lead candidate, TTX-MC138. FaZe Holdings Inc. (NASDAQ: FAZE) gained 46.9% to $0.2247 after falling over 4% on Friday. Avalo Therapeutics, Inc. (...

(Tuesday market open) Narrow, choppy trading typical of the days approaching a Federal Reserve interest rate decision seems likely to continue Tuesday. The Fed meeting begins today and concludes tomorrow, with markets baking in a likely pause in rate hikes, yet investors remain on edge about...

Raymond James increased the price target for Vital Energy, Inc. (NYSE: VTLE) from $54 to $67. Raymond James analyst John Freeman maintained an Outperform rating. Vital Energy shares rose 0.5% to $54.37 in pre-market trading. B of A Securities slashed PTC Therapeutics, Inc. (NASDAQ: PTCT) price...

Thursday after close, Lennar Corporation (NYSE: LEN) reported quarterly earnings of $3.91 per share, which beat the analyst consensus estimate of $3.51.  Quarterly sales of $8.73 billion beat the analyst consensus estimate of $8.45 billion but fell 2.28% from the same period...

(Thursday market open) A host of fresh economic data early Thursday showed the U.S. consumer and labor market remain in relatively good health, but wholesale inflation is ticking up a bit more than expected. The calculus isn’t likely to affect next week’s interest-rate decision...

The CNN Money Fear and Greed index showed further decline in overall sentiment among U.S. investors on Wednesday. U.S. stocks closed mixed on Wednesday, as investors digested hotter-than-expected inflation data for August. The annual inflation rate in the U.S. rose for a second consecutive month to...

(Monday market open) After a lackluster start to the month, Wall Street turns its collective attention to critical U.S. inflation data and a European Central Bank (ECB) meeting later this week. Things are looking up so far as investors seem slightly less risk-averse this morning....

(Friday market open) This short week is starting to feel long, and for many investors it probably can’t end soon enough. Stocks around the world remained in the red early Friday and major U.S. indexes are on pace for more losses, hurt by the troika of rising yields, a firm dollar, and...

Homebuilders have been a leading industry throughout 2023, defying fears that high interest rates would keep buyers away. KB Home (NYSE: KBH), a mid-cap in the industry, has been forming a bullish area of price consolidation that might be hard to spot on a chart.  KB Home is a component of the...

Raymond James analyst Buck Horne raised the rating on several homebuilding stocks, given his bullish stance on homebuilding industry growth. Industry metrics: The analyst is upbeat on substantial homebuilders’ YTD stock performance and surprising declines in existing home inventory to...